Rapigen and Eunpyeong St. Mary’s Hospital pose for a photo after signing a business agreement for joint research and development on Medical devices for In-Vitro Diagnosis in preparation for post-Covid 19.

The two organizations agreed to promote joint research on in-vitro diagnostic medical devices in the field of infectious diseases and develop an industry-academic cooperative relationship that leads to product technology and development and clinical trials. Rapigen and Eunpyeong St. Mary’s Hospital will actively cooperate in promoting R&D projects including localization of in vitro diagnostic medical devices and national projects.